Live Breaking News & Updates on Giuseppe Tarantini

Stay updated with breaking news from Giuseppe tarantini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

The studies highlight the need to choose the initial surgery or TAVI with an eye towards a second procedure down the line. ....

United States , Ann Arbor , New York , Giuseppe Tarantini , Robert Hawkins , Tommaso Fabris , Tsuyoshi Kaneko , Shinichi Fukuhara , Edwards Lifesciences , Gilbert Tang , University Of Padua Medical School , Msc University Of Michigan , Md Washington University School Of Medicine , University Of Michigan , Mount Sinai Health System , Md University Of Michigan , Society Of Thoracic Surgeons , International Registry , Thoracic Surgeons , Cardiovascular Interventions , Washington University School , Smart First , Padua Medical School ,

The Worst Redo Option After TAVR?

Choose the first procedure wisely, because repeats have mortality implications, researchers say ....

New York , United States , Ann Arbor , Tommaso Fabris , Gilbert Tang , Shinichi Fukuhara , Giuseppe Tarantini , University Of Michigan , Society Of Thoracic Surgeons , Mount Sinai Health System , University Of Padua Medical School , Thoracic Surgeons , New York City , Padua Medical School ,

MicroPort Scientific : ® Announces Release of TARGET-FIRST Study Design for the Firehawk Coronary Stent

Shanghai, China, 03 April 2023 - Shanghai MicroPort Medical Co., Ltd. recently announced the online publication on the EuroIntervention journal of the design of the Target-First study. This. | April 22, 2023 ....

Giuseppe Tarantini , Shanghai Microport Medical Group Co Ltd , University Hospital Of Padova , Microport Medical , University Hospital , Microport Scientific Corporation Stock Exchange , Press Release , He 853 Kyg608371046 ,

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

A new consensus statement provides some direction on the timing of PCI and TAVI and best valve type in different settings. ....

United States , Navitor Abbott , Giuseppe Tarantini , Edwards Lifesciences , European Association For Percutaneous Cardiovascular Interventions , Jenavalve Technology , Phd University Of Padova , Boston Scientific , European Association , Percutaneous Cardiovascular Interventions , European Society , Cardiology Working Group , Cardiovascular Surgery , Evolut Low Risk , Corevalve Extreme Risk , American College ,

Study backs Medtronic's Resolute Onyx drug-eluting stent

Data presented today at the EuroPCR 2022 event supported the use of the Medtronic (NYSE:MDT) Resolute Onyx drug-eluting stent. ....

Giuseppe Tarantini , Padua Medical School Head , Interventional Cardiology , Main With Resolute , Resolute Onyx ,